pharmadeals limited
pharmadeals limited Company Information
Company Number
04381898
Website
www.pharmadeals.netRegistered Address
3 forbury place, 23 forbury road, reading, RG1 3JH
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Telephone
01865600830
Next Accounts Due
September 2025
Group Structure
View All
Shareholders
iqvia ltd. 100%
pharmadeals limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMADEALS LIMITED at £0 based on a Turnover of £0 and 1.21x industry multiple (adjusted for size and gross margin).
pharmadeals limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMADEALS LIMITED at £0 based on an EBITDA of £0 and a 4.58x industry multiple (adjusted for size and gross margin).
pharmadeals limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMADEALS LIMITED at £0 based on Net Assets of £0 and 1.71x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmadeals Limited Overview
Pharmadeals Limited is a live company located in reading, RG1 3JH with a Companies House number of 04381898. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in February 2002, it's largest shareholder is iqvia ltd. with a 100% stake. Pharmadeals Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmadeals Limited Health Check
There is insufficient data available to calculate a health check for Pharmadeals Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Pharmadeals Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Pharmadeals Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmadeals Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmadeals Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Pharmadeals Limited
- - Industry AVG
PHARMADEALS LIMITED financials
Pharmadeals Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of 0. According to their latest financial statements, we estimate that Pharmadeals Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 330,000 | |||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 303,000 | |||||
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27,000 | |||||
| Admin Expenses | 185,700,000 | 74,600,000 | 0 | 0 | 57,000 | 62,000 | 0 | 0 | 47,000 | ||||||
| Operating Profit | -185,700,000 | -74,600,000 | 0 | 0 | -57,000 | -62,000 | 0 | 0 | -20,000 | ||||||
| Interest Payable | 0 | 59,000 | 128,000 | 176,000 | 157,000 | 203,000 | 221,000 | 143,000 | 0 | 0 | |||||
| Interest Receivable | 367,000 | 0 | 0 | 0 | 0 | 40,000 | 59,000 | 57,000 | 58,000 | 0 | |||||
| Pre-Tax Profit | 90,990,000 | 24,224,000 | -128,000 | -176,000 | -157,000 | -220,000 | -224,000 | -86,000 | 58,000 | -20,000 | |||||
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | |||||
| Profit After Tax | 90,990,000 | 24,224,000 | -128,000 | -176,000 | -157,000 | -220,000 | -224,000 | -86,000 | 58,000 | -17,000 | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Retained Profit | 90,990,000 | 24,224,000 | -128,000 | -176,000 | -157,000 | -220,000 | -224,000 | -86,000 | 58,000 | -17,000 | |||||
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 158,000 | |||||
| Number Of Employees | 2 | ||||||||||||||
| EBITDA* | -185,700,000 | -74,600,000 | 0 | 0 | -57,000 | -62,000 | 0 | 0 | -20,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 185,700,000 | 260,300,000 | 260,300,000 | 260,300,000 | 258,800,000 | 257,000,000 | 257,000,000 | 233,500,000 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 185,700,000 | 260,300,000 | 260,300,000 | 260,300,000 | 258,800,000 | 257,000,000 | 257,000,000 | 233,500,000 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87,000 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 87,033,000 | 0 | 0 | 393,000 | 393,000 | 1,705,000 | 1,645,000 | 1,588,000 | 0 | 40,000 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130,000 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55,000 | 0 | 0 | 56,000 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 0 | 0 | 87,033,000 | 1,000 | 0 | 393,000 | 393,000 | 1,705,000 | 1,700,000 | 1,588,000 | 0 | 313,000 | 0 | 0 | 0 |
| total assets | 0 | 0 | 272,733,000 | 260,301,000 | 260,300,000 | 260,693,000 | 259,193,000 | 258,705,000 | 258,700,000 | 235,088,000 | 0 | 313,000 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50,000 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 11,792,000 | 11,663,000 | 11,880,000 | 10,223,000 | 9,515,000 | 9,286,000 | 0 | 0 | 69,000 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 211,000 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 11,792,000 | 11,663,000 | 11,880,000 | 10,223,000 | 9,515,000 | 9,286,000 | 0 | 0 | 330,000 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 11,792,000 | 11,663,000 | 11,880,000 | 10,223,000 | 9,515,000 | 9,286,000 | 0 | 0 | 330,000 | 0 | 0 | 0 |
| net assets | 0 | 0 | 272,733,000 | 248,509,000 | 248,637,000 | 248,813,000 | 248,970,000 | 249,190,000 | 249,414,000 | 235,088,000 | 0 | -17,000 | 0 | 0 | 0 |
| total shareholders funds | 0 | 0 | 272,733,000 | 248,509,000 | 248,637,000 | 248,813,000 | 248,970,000 | 249,190,000 | 249,414,000 | 235,088,000 | 0 | -17,000 | 0 | 0 | 0 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -185,700,000 | -74,600,000 | 0 | 0 | -57,000 | -62,000 | 0 | 0 | -20,000 | ||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | |||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | -87,033,000 | 87,032,000 | 1,000 | -393,000 | 0 | -1,312,000 | 60,000 | 57,000 | 1,588,000 | -257,000 | 257,000 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50,000 | 50,000 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -211,000 | 211,000 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -98,667,000 | -161,632,000 | -1,000 | 0 | 1,255,000 | -122,000 | -57,000 | -1,588,000 | -13,000 | ||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | -185,700,000 | -74,600,000 | 0 | 0 | 1,500,000 | 1,800,000 | 0 | 23,500,000 | 233,500,000 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | -11,792,000 | 129,000 | -217,000 | 1,657,000 | 708,000 | 229,000 | 9,286,000 | 0 | -69,000 | 69,000 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 367,000 | -59,000 | -128,000 | -176,000 | -157,000 | -163,000 | -162,000 | -86,000 | 58,000 | 0 | |||||
| cash flow from financing | -363,356,000 | -11,851,000 | 1,000 | -393,000 | 1,500,000 | 545,000 | 67,000 | 23,612,000 | 235,088,000 | 69,000 | |||||
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -55,000 | 55,000 | 0 | -56,000 | 56,000 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -55,000 | 55,000 | 0 | -56,000 | 56,000 | 0 | 0 | 0 |
pharmadeals limited Credit Report and Business Information
Pharmadeals Limited Competitor Analysis
Perform a competitor analysis for pharmadeals limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
pharmadeals limited Ownership
PHARMADEALS LIMITED group structure
Pharmadeals Limited has no subsidiary companies.
Ultimate parent company
IQVIA HOLDINGS INC
#0013898
2 parents
PHARMADEALS LIMITED
04381898
pharmadeals limited directors
Pharmadeals Limited currently has 2 directors. The longest serving directors include Mr Timothy Sheppard (Jun 2022) and Mr James Berkshire (Jun 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Timothy Sheppard | England | 53 years | Jun 2022 | - | Director |
| Mr James Berkshire | United Kingdom | 50 years | Jun 2022 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
0
0%
total assets
0
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
pharmadeals limited company details
company number
04381898
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
February 2002
age
22
accounts
Dormant
ultimate parent company
previous names
pharmaequity limited (May 2012)
incorporated
UK
address
3 forbury place, 23 forbury road, reading, RG1 3JH
last accounts submitted
December 2023
pharmadeals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmadeals limited.
pharmadeals limited Companies House Filings - See Documents
| date | description | view/download |
|---|
